Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism

J Neurol Sci. 2011 Feb 15;301(1-2):12-3. doi: 10.1016/j.jns.2010.11.017. Epub 2010 Dec 16.

Abstract

The pathomechanism of amyotrophic lateral sclerosis (ALS) with parkinsonism (ALS-P) has not been clarified. We report two patients with ALS-P who showed dysfunction of the nigrostriatal system. The first patient showed tremor dominant, asymmetric parkinsonism which was more severe on the right side, while the second patient exhibited predominant freezing of gait. Both patients showed reduced uptake of [¹⁸F] N-(3-fluoropropyl)-2ß-carbon ethoxy-3ß-(4-iodophenyl) nortropane (¹⁸F-FP-CIT) in the posterior parts of bilateral putamina on positron emission tomography (PET). Based on our PET findings, we suggest that presynaptic nigrostriatal dysfunction may be involved in the pathomechanism of parkinsonism combined with ALS.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amyotrophic Lateral Sclerosis / complications
  • Amyotrophic Lateral Sclerosis / diagnostic imaging
  • Amyotrophic Lateral Sclerosis / physiopathology*
  • Antiparkinson Agents / therapeutic use
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / physiopathology*
  • Fluorine Radioisotopes
  • Gait Disorders, Neurologic / etiology
  • Gait Disorders, Neurologic / physiopathology
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinsonian Disorders / diagnostic imaging
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / etiology
  • Parkinsonian Disorders / physiopathology*
  • Positron-Emission Tomography*
  • Presynaptic Terminals / physiology
  • Putamen / diagnostic imaging
  • Putamen / physiopathology
  • Radiopharmaceuticals
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / physiopathology*
  • Tremor / drug therapy
  • Tremor / etiology
  • Tremor / physiopathology
  • Tropanes

Substances

  • Antiparkinson Agents
  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
  • Levodopa